BioCryst to Present at Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will […]
Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference
EWING, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President […]
Plug Power Announces 2018 Third Quarter Results
LATHAM, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leader in providing energy solutions that […]
Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions
Results to be presented show a significant reduction of Lp(a) levels, favorable safety and tolerability profile BOSTON and CARLSBAD, Calif., […]
Chimerix Announces Third Quarter 2018 Financial Results
– Conference Call at 8:30 a.m. ET Today – DURHAM, N.C., Nov. 08, 2018 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical […]
Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114
CDX-6114 meets safety and tolerability endpoints REDWOOD CITY, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a […]
Sorrento Therapeutics Closes Five-Year Term Loan Financing for Up to $150 Million
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a clinical-stage immunotherapy biotech company, announces the […]
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
LEXINGTON, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of […]
Merus to Present at the Jefferies 2018 London Healthcare Conference
UTRECHT, The Netherlands, Nov. 08, 2018 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody […]
Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
ALPHARETTA, Ga., Nov. 08, 2018 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ: CLSD), a biopharmaceutical company dedicated to developing treatments […]
